China SXT Pharmaceuticals, Inc. Operating Cash Flow
China SXT Pharmaceuticals, Inc. (SXTC) reported Operating Cash Flow of -$4.02 million for the 12-month period ending 2026-03-31, per its 20-F filed 2026-07-01.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-07-01
| Period end | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|
| 2026-03-31 | -$4.02M 20-F · filed 2026-07-01 | |
| 2025-09-30 | -$1.75M 6-K · filed 2025-12-31 | |
| 2025-03-31 | -$2.35M 20-F · filed 2026-07-01 | |
| 2024-09-30 | -$1.36M 6-K · filed 2025-12-31 | |
| 2024-03-31 | -$1.93M 20-F · filed 2026-07-01 | |
| 2023-09-30 | -$579.57K 6-K · filed 2025-03-28 | |
| 2023-03-31 | -$80.76K 20-F · filed 2025-07-31 | |
| 2022-09-30 | -$549.13K 6-K · filed 2024-04-05 | |
| 2022-03-31 | $268.29K 20-F · filed 2024-08-13 | |
| 2021-09-30 | -$312.35K 6-K · filed 2023-02-24 | |
| 2021-03-31 | -$1.32M 20-F · filed 2023-07-31 | |
| 2020-09-30 | -$333.51K 6-K · filed 2022-01-14 | |
| 2020-03-31 | $934.25K 20-F/A · filed 2023-05-19 | |
| 2019-09-30 | -$2.02M 6-K · filed 2021-01-28 | |
| 2019-03-31 | $239.19K 20-F · filed 2021-08-13 | |
| 2018-09-30 | -$467.82K 6-K/A · filed 2020-05-22 | |
| 2018-03-31 | $1.92M 20-F · filed 2020-07-31 | |
| 2017-03-31 | $293.04K 20-F · filed 2019-08-15 |